Position in MRVI
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$403,657
-$85,672 QoQ
Shares Held
142,635
-5.3% QoQ
Ownership
0.055%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 15.759105408910855.ToString("F0")%
Shared 0.ToString("F0")%
None 84.24089459108914.ToString("F0")%
Common Shares in MRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RHUMBLINE ADVISERS holds $1,238,262,141 across 282 Biotechnology names. MRVI ranks #170 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
423,140 | $188,948,935 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,781 | $121,907,911 | |
| 3 | INCY |
Incyte Corp
|
693,665 | $65,287,749 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
195,277 | $64,611,300 | |
| 5 | INSM |
INSMED Inc
|
272,615 | $44,578,004 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
164,542 | $31,106,665 | |
| 7 | EXEL |
Exelixis, Inc.
|
723,931 | $31,049,400 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,113,266 | $30,837,468 |
All Filings in MRVI
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $403,657 | 142,635 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $489,329 | 150,563 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $501,047 | 174,581 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $470,605 | 195,272 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $358,753 | 162,332 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $1,009,454 | 185,221 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $1,400,309 | 168,509 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,227,861 | 171,489 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $1,140,399 | 131,534 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $957,976 | 146,256 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $1,369,270 | 136,927 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $1,979,315 | 159,237 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $1,831,022 | 130,694 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,691,885 | 118,231 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,846,135 | 111,482 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $3,008,647 | 105,901 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $3,306,068 | 93,736 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $4,040,333 | 96,428 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $4,164,487 | 84,851 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,818,986 | 67,553 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $2,276,077 | 63,863 | Shares | Sole | 2021-05-06 | |
| No filing history on record for this holder in this stock. | ||||||